Expert Pitch
University of California San Diego Health

Why Getting a Flu Shot This Year is Critical

No one knows what will happen when flu season arrives, compounding the ongoing COVID-19 pandemic, but one thing is certain: It’s time to get your flu shot 

The looming flu season poses the prospect of a “twindemic,” with the diseases converging to create an unprecedented public health threat. Experts at UC San Diego Health can offer perspective on what to expect, how seasonal influenza and COVID-19 differ in diagnosis and treatment, and most importantly, how to prepare. Hint: Get vaccinated for the flu now! 

Topics of DiscussionDiagnosing which is which: flu or COVID-19

  • Differences in treatment 

Michele Ritter, MD, infectious disease specialist and director of the COVID-19 outpatient clinic

  • Treating COVID-19 and the flu, especially at home 

Francesca Torriani, MD, program director of Infection Prevention and Clinical Epidemiology

  • COVID-19 and influenza as public health threats
  • Importance of vaccinations
  • Who should be vaccinated for the flu 

Amy Bellinghausen, MD, pulmonologist

  • Comparative impact of flu and COVID-19 upon the respiratory system 

Davey Smith, MD, translational research virologist and head of the Division of Infectious Diseases and Global Public Health at UC San Diego School of Medicine

  • General status of COVID-19 vaccination efforts 

Pascal Gagneux, PhD, professor of pathology and evolutionary biologist

  • Evolutionary history and behaviors of viruses 

“We don’t know how the convergence of the flu and COVID-19 will affect people,” said Torriani. “We don’t yet know whether there is greater or lesser risk of infection for one or the other disease — or what the risk of co-infection might be. What we can say is that the populations at risk for severe disease and death are the same, and so you want to avoid any infection that can be mitigated by vaccination.”

###




Filters close

Showing results

110 of 3821
Newswise: UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
Released: 28-Oct-2020 5:20 PM EDT
UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
UC Davis Health

UC Davis Health is one of only a handful of health systems in the U.S. to launch a Post-COVID-19 Clinic to care for long-haul COVID patients whose symptoms go on and on, sometimes for months, with no clear explanation or avenue for treatment.

Newswise: Most People Mount a Strong Antibody Response to 
SARS-CoV-2 That Does Not Decline Rapidly
Released: 28-Oct-2020 5:20 PM EDT
Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly
Mount Sinai Health System

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

Newswise: 45a1c2a0-c0a4-11ea-b53e-cb3f2ed770b1.jpg
Released: 28-Oct-2020 4:00 PM EDT
Investigator on the AtraZeneca vaccine trial will take questions at Live Event on Oct. 29, 3PM
Keck Medicine of USC

Dr. Edward Jones-Lopez, joins a Newswise Live Expert Panel on Thursday Oct. 29, from 3-4 PM EDT to discuss the AstraZenea COVID-19 vaccine trial.

Released: 28-Oct-2020 4:00 PM EDT
"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT
Newswise

"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT

Newswise: Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Released: 28-Oct-2020 2:15 PM EDT
Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Oak Ridge National Laboratory

A collaboration between the Department of Energy’s Oak Ridge National Laboratory and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.

Released: 28-Oct-2020 1:55 PM EDT
What EEGs tell us about COVID-19 and the brain
Baylor College of Medicine

Throughout the pandemic, healthcare workers have seen more than just the lungs affected by COVID-19. Doctors have reported neurological complications including stroke, headache and seizures, but the information is limited to a number of individual reports that are not reflective of a larger population.

Released: 28-Oct-2020 1:50 PM EDT
A new playbook: COVID-19, athletes' hearts and return to play
Massachusetts General Hospital

Reports have indicated that COVID-19 may cause heart damage in hospitalized patients with severe cases of the disease, but it's unclear whether cardiac injury also occurs in infected patients who are asymptomatic or experience only mild symptoms.

Newswise: 0815UCI20052-1069-768x512.jpg
Released: 28-Oct-2020 1:05 PM EDT
Antibody screening finds COVID-19 nearly 7 times more prevalent in O.C. than thought
University of California, Irvine

Irvine, Calif., Oct. 28, 2020 — Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent. Latino and low-income residents had the highest prevalence of SARS-CoV-02 antibodies with rates of 17 percent and 15 percent, respectively.

Released: 28-Oct-2020 1:05 PM EDT
Researchers find confusion over masks for wildfire, COVID-19 crises
Stanford School of Earth, Energy & Environmental Sciences

To mask or not to mask - and which mask to use? With public health guidance about masks in the United States confused by political hedging, clarity around mask use is increasingly important, especially as the western U.S. battles the twin crises of wildfire smoke and COVID-19.


Showing results

110 of 3821

close
2.02244